Question 1

What are the differences between Travoprost and Latanoprost in terms of effectiveness?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma clinical trial (NCT00051181). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma clinical trial (NCT00051181). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my eye pressure be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma clinical trial (NCT00051181). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma clinical trial (NCT00051181). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with switching medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma clinical trial (NCT00051181). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will the treatment last, and how often will I need to visit for check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma clinical trial (NCT00051181). Contact the study team or your healthcare provider for specific answers.

What this study is about